Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
- PMID: 1470917
- DOI: 10.1126/science.1470917
Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene
Abstract
Vaccine protection against the human immunodeficiency virus (HIV) and the related simian immunodeficiency virus (SIV) in animal models is proving to be a difficult task. The difficulty is due in large part to the persistent, unrelenting nature of HIV and SIV infection once infection is initiated. SIV with a constructed deletion in the auxiliary gene nef replicates poorly in rhesus monkeys and appears to be nonpathogenic in this normally susceptible host. Rhesus monkeys vaccinated with live SIV deleted in nef were completely protected against challenge by intravenous inoculation of live, pathogenic SIV. Deletion of nef or of multiple genetic elements from HIV may provide the means for creating a safe, effective, live attenuated vaccine to protect against acquired immunodeficiency syndrome (AIDS).
Comment in
-
AIDS vaccines: is older better?Science. 1992 Dec 18;258(5090):1880-1. doi: 10.1126/science.1470911. Science. 1992. PMID: 1470911 No abstract available.
Similar articles
-
Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion.Immunol Lett. 1996 Jun;51(1-2):129-35. doi: 10.1016/0165-2478(96)02567-9. Immunol Lett. 1996. PMID: 8811357
-
Live attenuated SIV vaccines are not effective in a postexposure vaccination model.AIDS Res Hum Retroviruses. 1997 May 1;13(7):593-9. doi: 10.1089/aid.1997.13.593. AIDS Res Hum Retroviruses. 1997. PMID: 9135877 Clinical Trial.
-
Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.Virology. 1995 Oct 1;212(2):392-7. doi: 10.1006/viro.1995.1496. Virology. 1995. PMID: 7571408
-
Protective immunity induced by live attenuated simian immunodeficiency virus.Curr Opin Immunol. 1998 Aug;10(4):436-43. doi: 10.1016/s0952-7915(98)80118-0. Curr Opin Immunol. 1998. PMID: 9722920 Review.
-
Live attenuated AIDS viruses as vaccines: promise or peril?Immunol Rev. 1999 Aug;170:135-49. doi: 10.1111/j.1600-065x.1999.tb01335.x. Immunol Rev. 1999. PMID: 10566148 Review.
Cited by
-
Simian immunodeficiency virus interactions with macaque dendritic cells.Adv Exp Med Biol. 2013;762:155-81. doi: 10.1007/978-1-4614-4433-6_6. Adv Exp Med Biol. 2013. PMID: 22975875 Free PMC article. Review.
-
Reproducing SIVΔnef vaccine correlates of protection: trimeric gp41 antibody concentrated at mucosal front lines.AIDS. 2016 Oct 23;30(16):2427-2438. doi: 10.1097/QAD.0000000000001199. AIDS. 2016. PMID: 27428745 Free PMC article.
-
Persistence of pathogenic challenge virus in macaques protected by simian immunodeficiency virus SIVmacDeltanef.J Virol. 2001 Feb;75(3):1507-15. doi: 10.1128/JVI.75.3.1507-1515.2001. J Virol. 2001. PMID: 11152522 Free PMC article.
-
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: protection from an intraclade challenge administered systemically or mucosally by an attenuated vaccine.J Virol. 2003 Oct;77(20):10740-50. doi: 10.1128/jvi.77.20.10740-10750.2003. J Virol. 2003. PMID: 14512524 Free PMC article.
-
Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination.J Virol. 2001 Jun;75(11):5151-8. doi: 10.1128/JVI.75.11.5151-5158.2001. J Virol. 2001. PMID: 11333896 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources